MANNKIND CORP Operating Leases, Future Minimum Payments Due, Next Twelve Months
MANNKIND CORP (MNKD) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $947.16 thousand as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2019-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $947.16K.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $522.00K.
- 2012-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $21.00K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $947.16K 10-K · filed 2019-02-26 |
| 2017-12-31 | $522.00K 10-K · filed 2018-02-27 |
| 2012-12-31 | $21.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |